Open Access

Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension

  • Authors:
    • Nosheen Mushtaq
    • Safdar Hussain
    • Siruo Zhang
    • Lu Yuan
    • Huan Li
    • Shakir Ullah
    • Yan Wang
    • Jiru Xu
  • View Affiliations

  • Published online on: June 6, 2019     https://doi.org/10.3892/ijmm.2019.4235
  • Pages: 513-522
  • Copyright: © Mushtaq et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hypertension has become a major risk factor for many diseases, including cardiovascular, cerebrovascular and kidney disorders. It has been reported that the composition of human gut microbiota is changed during the progression of cardiovascular and kidney diseases. The current study aimed to qualitatively and quantitatively compare the composition of gut microbiota between patients with hypertension and healthy controls. Fecal samples were collected from 50 patients diagnosed with grade 3 hypertension and 30 healthy controls. Touchdown PCR‑denaturing gradient gel electrophoresis with primers specifically targeting the V3 region of 16S ribosomal RNA, and quantitative PCR, were performed to characterize all the samples. High‑throughput sequencing of the V3‑V4 regions was performed on 30 randomly selected samples. By comparing diversity and richness indices, the gut microbiome of the hypertensive individuals was found to be more diverse than that of the healthy controls. Among the main bacterial phlya that reside in the gut, Bacteroidetes, Firmicutes and Proteobacteria were dominant in all the samples; however the Firmicutes to Bacteroidetes ratio was variable, with a significant increase in the patients with hypertension compared with the healthy control group. In addition, at the genus level, there was an increased abundance of Prevotella_9, Megasphaera, Parasutterella and Escherichia‑Shigella in patients with hypertension, while Bacteroides and Faecalibacterium were decreased. These results suggested that the human gut microbiota is altered in hypertension, and understanding the mechanism of these changes in microbial composition may open up new insights, and help to treat hypertension and other related diseases.

References

1 

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet. 380:2224–2260. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Lackland DT and Weber MA: Global burden of cardiovascular disease and stroke: Hypertension at the core. Can J Cardiol. 31:569–571. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J and He J: Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 134:441–450. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, Hollister EB and Bryan RM Jr: Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 67:469–474. 2016. View Article : Google Scholar :

5 

Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, et al: Gut dysbiosis is linked to hypertension. Hypertension. 65:1331–1340. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S and Joe B: Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics. 47:187–197. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Nutting CW, Islam S and Daugirdas JT: Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Physiol. 261:H561–H567. 1991.PubMed/NCBI

8 

Pluznick JL, Zou DJ, Zhang X, Yan Q, Rodriguez-Gil DJ, Eisner C, Wells E, Greer CA, Wang T, Firestein S, et al: Functional expression of the olfactory signaling system in the kidney. Proc Natl Acad Sci USA. 106:2059–2064. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Galla S, Chakraborty S, Mell B, Vijay-Kumar M and Joe B: Microbiotal-host interactions and hypertension. Physiology (Bethesda). 32:224–233. 2017.

10 

Menni C, Graham D, Kastenmuller G, Alharbi NH, Alsanosi SM, McBride M, Mangino M, Titcombe P, Shin SY, Psatha M, et al: Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension. 66:422–429. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Thursby E and Juge N: Introduction to the human gut microbiota. Biochem J. 474:1823–1836. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Sekirov I, Russell SL, Antunes LC and Finlay BB: Gut micro-biota in health and disease. Physiol Rev. 90:859–904. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Sanz Y and Moya-Perez A: Microbiota, inflammation and obesity. Adv Exp Med Biol. 817:291–317. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Mariat D, Firmesse O, Levenez F, Guimarăes V, Sokol H, Doré J, Corthier G and Furet JP: The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9:1232009. View Article : Google Scholar : PubMed/NCBI

15 

Khalesi S, Sun J, Buys N and Jayasinghe R: Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension. 64:897–903. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Mann GV: Studies of a surfactant and cholesteremia in the Maasai. Am J Clinl Nutr. 27:464–469. 1974. View Article : Google Scholar

17 

Kiessling G, Schneider J and Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 56:843–849. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Collado MC, Rautava S, Isolauri E and Salminen S: Gut micro-biota: A source of novel tools to reduce the risk of human disease? Pediatr Res. 77:182–188. 2015. View Article : Google Scholar

19 

Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N and Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 104:13780–13785. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464:59–65. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Ley RE, Turnbaugh PJ, Klein S and Gordon JI: Microbial ecology: Human gut microbes associated with obesity. Nature. 444:1022–1023. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Kau AL, Ahern PP, Griffin NW, Goodman AL and Gordon JI: Human nutrition, the gut microbiome and the immune system. Nature. 474:327–336. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Muyzer G, de Waal EC and Uitterlinden AG: Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol. 59:695–700. 1993.PubMed/NCBI

24 

Fromin N, Hamelin J, Tarnawski S, Roesti D, Jourdain-Miserez K, Forestier N, Teyssier-Cuvelle S, Gillet F, Aragno M and Rossi P: Statistical analysis of denaturing gel electrophoresis (DGE) fingerprinting patterns. Environ Microbiol. 4:634–643. 2002. View Article : Google Scholar : PubMed/NCBI

25 

Lu Y, Xie L and Chen J: A novel procedure for absolute real-time quantification of gene expression patterns. Plant Methods. 8:92012. View Article : Google Scholar : PubMed/NCBI

26 

Sun H, Tang JW, Fang CL, Yao XH, Wu YF, Wang X and Feng J: Molecular analysis of intestinal bacterial microbiota of broiler chickens fed diets containing fermented cottonseed meal. Poult Sci. 92:392–401. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Peiffer JA, Spor A, Koren O, Jin Z, Tringe SG, Dangl JL, Buckler ES and Ley RE: Diversity and heritability of the maize rhizosphere microbiome under field conditions. Proc Natl Acad Sci USA. 110:6548–6553. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al: QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 7:335–336. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Magoc T and Salzberg SL: FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 27:2957–2963. 2011. View Article : Google Scholar : PubMed/NCBI

30 

DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P and Andersen GL: Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 72:5069–5072. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Edgar RC: Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 26:2460–2461. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Wang Q, Garrity GM, Tiedje JM and Cole JR: Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. App Environ Microbiol. 73:5261–5267. 2007. View Article : Google Scholar

33 

Team RC: R: A language and environment for statistical computing. R foundation for statistical computing; Vienna, Austria: 2012

34 

De Vuyst L, Moens F, Selak M, Riviere A and Leroy F: Summer meeting 2013: Growth and physiology of bifidobacteria. J Appl Microbiol. 116:477–491. 2014. View Article : Google Scholar

35 

Kearney PM, Whelton M, Reynolds K, Whelton PK and He J: Worldwide prevalence of hypertension: A systematic review. J Hypertens. 22:11–19. 2004. View Article : Google Scholar : PubMed/NCBI

36 

Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, Macmahon S and Neal B; PROGRESS Collaborative Group: Lower target blood pressures are safe and effective for the prevention of recurrent stroke: The PROGRESS trial. J Hyperten. 24:1201–1208. 2006. View Article : Google Scholar

37 

Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, et al: Primary prevention of ischemic stroke: A guideline from the american heart association/American stroke association stroke council: Cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: The American academy of neurology affirms the value of this guideline. Stroke. 37:1583–1633. 2006. View Article : Google Scholar : PubMed/NCBI

38 

Tilg H and Kaser A: Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 121:2126–2132. 2011. View Article : Google Scholar : PubMed/NCBI

39 

Duca FA, Sakar Y, Lepage P, Devime F, Langelier B, Doré J and Covasa M: Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes. 63:1624–1636. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Pedersen R, Andersen AD, Molbak L, Stagsted J and Boye M: Changes in the gut microbiota of cloned and non-cloned control pigs during development of obesity: Gut microbiota during development of obesity in cloned pigs. BMC Microbiol. 13:302013. View Article : Google Scholar : PubMed/NCBI

41 

Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS and Flint HJ: Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr. 91:915–923. 2004. View Article : Google Scholar : PubMed/NCBI

42 

Watanabe Y, Nagai F and Morotomi M: Characterization of Phascolarctobacterium succinatutens sp. Nov.an asaccharolytic, succinate-utilizing bacterium isolated from human feces. Appl Environ Microbiol. 78:511–518. 2012. View Article : Google Scholar :

43 

Wong JM, de Souza R, Kendall CW, Emam A and Jenkins DJ: Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol. 40:235–243. 2006. View Article : Google Scholar : PubMed/NCBI

44 

Marchandin H and Jumas-Bilak E: The family Veillonellaceae: The prokaryotes: Firmicutes and tenericutes. Rosenberg E, DeLong EF, Lory S, Stackebrandt E and Thompson F: Springer, Berlin Heidelberg; Berlin, Heidelberg: pp. 433–453. 2014

45 

Hofer U: Microbiome: Anelloviridae go viral. Nat Rev Microbiol. 12:4–5. 2014. View Article : Google Scholar

46 

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, et al: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. ELife. 2:e012022013. View Article : Google Scholar : PubMed/NCBI

47 

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al: Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 5:142017. View Article : Google Scholar : PubMed/NCBI

48 

Zhang X, Wang H, Yin P, Fan H, Sun L and Liu Y: Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. Lipids Health Dis. 16:442017. View Article : Google Scholar : PubMed/NCBI

49 

Noble EE, Hsu TM, Jones RB, Fodor AA, Goran MI and Kanoski SE: Early-life sugar consumption affects the rat micro-biome independently of obesity. J Nutr. 147:20–28. 2017. View Article : Google Scholar

50 

Chiodini RJ, Dowd SE, Chamberlin WM, Galandiuk S, Davis B and Glassing A: Microbial population differentials between mucosal and submucosal intestinal tissues in advanced crohn's disease of the ileum. PLoS One. 10:e01343822015. View Article : Google Scholar : PubMed/NCBI

51 

Huang C, Chen J, Wang J, Zhou H, Lu Y, Louz L, Zheng J, Tian L, Wang X, Cao Z and Zeng Y: Dysbiosis of intestinal microbiota and decreased antimicrobial peptide level in paneth cells during hypertriglyceridemia-related acute necrotizing pancreatitis in rats. Front Microbiol. 8:7762017. View Article : Google Scholar : PubMed/NCBI

52 

Amani J, Ahmadpour A, Imani Fooladi AA and Nazarian S: Detection of E. coli O157:H7 and Shigella dysenteriae toxins in clinical samples by PCR-ELISA. Braz J Infect Dis. 19:278–284. 2015. View Article : Google Scholar : PubMed/NCBI

53 

Miquel S, Martin R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM and Langella P: Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 16:255–261. 2013. View Article : Google Scholar : PubMed/NCBI

54 

Cao Y, Shen J and Ran ZH: Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: A meta-analysis and systematic review of the literature. Gastroenterol Res Pract. 2014:8727252014. View Article : Google Scholar : PubMed/NCBI

55 

Vinolo MA, Rodrigues HG, Nachbar RT and Curi R: Regulation of inflammation by short chain fatty acids. Nutrients. 3:858–876. 2011. View Article : Google Scholar

56 

Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G and Marsh DJ: Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 7:e352402012. View Article : Google Scholar : PubMed/NCBI

57 

Berni Canani R, Di Costanzo M and Leone L: The epigenetic effects of butyrate: Potential therapeutic implications for clinical practice. Clin Epigenetics. 4:42012. View Article : Google Scholar : PubMed/NCBI

58 

Henagan TM, Stefanska B, Fang Z, Navard AM, Ye J, Lenard NR and Devarshi PP: Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning. Br J Pharmacol. 172:2782–2798. 2015. View Article : Google Scholar : PubMed/NCBI

59 

Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT and Ye J: Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 58:1509–1517. 2009. View Article : Google Scholar : PubMed/NCBI

60 

Yan Q, Gu Y, Li X, Yang W, Jia L, Chen C, Han X, Huang Y, Zhao L, Li P, et al: Alterations of the gut microbiome in hypertension. Front Cell Infect Microbiol. 7:3812017. View Article : Google Scholar : PubMed/NCBI

61 

Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD and de Vos WM: Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 68:3401–3407. 2002. View Article : Google Scholar : PubMed/NCBI

62 

Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE and Relman DA: Diversity of the human intestinal microbial flora. Science. 308:1635–1638. 2005. View Article : Google Scholar : PubMed/NCBI

63 

Muyzer G: DGGE/TGGE a method for identifying genes from natural ecosystems. Curr Opin Microbiol. 2:317–322. 1999. View Article : Google Scholar : PubMed/NCBI

64 

Rinttila T, Kassinen A, Malinen E, Krogius L and Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 97:1166–1177. 2004. View Article : Google Scholar : PubMed/NCBI

65 

Ponnusamy K, Choi JN, Kim J, Lee SY and Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 60:817–827. 2011. View Article : Google Scholar : PubMed/NCBI

66 

Jalanka-Tuovinen J, Salonen A, Nikkila J, Immonen O, Kekkonen R, Lahti L, Palva A and de Vos WM: Intestinal micro-biota in healthy adults: Temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One. 6:e230352011. View Article : Google Scholar

67 

Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A and Haslberger AG: Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol. 44:440–446. 2009. View Article : Google Scholar : PubMed/NCBI

68 

Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM and Savelkoul PH: Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol. 40:4423–4427. 2002. View Article : Google Scholar : PubMed/NCBI

69 

Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H and Tanaka R: Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol. 68:5445–5451. 2002. View Article : Google Scholar : PubMed/NCBI

70 

Bartosch S, Fite A, Macfarlane GT and McMurdo ME: Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 70:3575–3581. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August 2019
Volume 44 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Mushtaq, N., Hussain, S., Zhang, S., Yuan, L., Li, H., Ullah, S. ... Xu, J. (2019). Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension. International Journal of Molecular Medicine, 44, 513-522. https://doi.org/10.3892/ijmm.2019.4235
MLA
Mushtaq, N., Hussain, S., Zhang, S., Yuan, L., Li, H., Ullah, S., Wang, Y., Xu, J."Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension". International Journal of Molecular Medicine 44.2 (2019): 513-522.
Chicago
Mushtaq, N., Hussain, S., Zhang, S., Yuan, L., Li, H., Ullah, S., Wang, Y., Xu, J."Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension". International Journal of Molecular Medicine 44, no. 2 (2019): 513-522. https://doi.org/10.3892/ijmm.2019.4235